To ascertain whether CASP4 influences immunotherapy by affecting tumor-infiltrating immune cells, we analyzed the potential association between CASP4 expression and tumor-infiltrating immune cells in multiple cancer types based on the TIMER database. This evidence concerns the gene CASP4 and neoplasm.